Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,467,430,93
Msft1,82
Nokia3,38053,44951,09
IBM-1,05
Mercedes-Benz Group AG74,3674,381,56
PFE0,55
27.04.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 26.04.2024
MediClin AG (MEDG.DE, Xetra)
Závěr k 26.4.2024 Změna (%) Změna (EUR) Objem obchodů (EUR)
2,82 0,00 0,00 5 278
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 27.04.2024
Popis společnosti
Obecné informace
Název společnostiMediClin AG
TickerMED
Kmenové akcie:Ordinary Shares
RICMEDG.DE
ISINDE0006595101
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 7 016
Akcie v oběhu k 31.12.2023 47 500 000
MěnaEUR
Kontaktní informace
UliceOkenstr. 27
MěstoOFFENBURG
PSČ77652
ZeměGermany
Kontatní osobaEnder Gulcan
Funkce kontaktní osobyHead of Investor Relations and Sustainability
Telefon 497 814 880
Fax49781488133
Kontatní telefon49 781 488 184

Business Summary: Mediclin AG is a Germany-based operators of healthcare facilities. The Company operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, MediClin AG revenues increased 6% to EUR766.7M. Net loss totaled EUR10.8M vs. income of EUR9.4M. Revenues reflect Post Acute segment increase of 5% to EUR451.2M, Other Activities segment increase of 12% to EUR102.6M, Utilization of Licensed Beds - Post-A. increase of 9% to 98.4%. Net loss reflects Acute segment loss increase from EUR4.4M to EUR39.9M.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Hospitals, Clinics & Primary Care Services
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSGeneral Medical and Surgical Hospitals
NAICSSpecialty (except Psychiatric and Substance Abuse) Hospitals
NAICS2007General Medical and Surgical Hospitals
NAICS2007Specialty (except Psychiatric and Substance Abuse) Hospitals
NAICS1997General Medical and Surgical Hospitals
NAICS1997Specialty (except Psychiatric and Substance Abuse) Hospitals
SICGeneral Med'L/surgical Hospitals
SICSpecialty Hospitals Not Psych'Ric



  • Poslední aktualizace: 27.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Supervisory BoardJan Liersch5122.11.201922.11.2019
Chairman of the Management Board, Chief Executive OfficerJoachim Ramming-01.08.202101.08.2021
Vice Chairman of the Supervisory Board, Employee RepresentativeHans Hilpert-13.03.200213.03.2002
Chief Financial Officer, Member of the Management BoardTino Fritz4401.09.201820.02.2018
Chief Operating Officer, Member of the Management BoardThomas Piefke-01.10.202301.10.2023